Here we set out to define the role of ASXL2 in normal and malignant haematopoiesis, to compare its effects on gene expression and chromatin state to those of ASXL1, and to understand the functional basis for ASXL2 mutations in the context of AML1-ETO-mediated AML. The gene discussed is RUNX1; the disease is acute myeloid leukemia.